CLOV (Clover Health Investments, Corp) Stock Analysis - Financials
Clover Health Investments, Corp (CLOV) is a publicly traded Healthcare sector company. As of May 21, 2026, CLOV trades at $3.59 with a market cap of $1.79B and a P/E ratio of 0.00. CLOV moved +2.57% today. Year to date, CLOV is +38.61%; over the trailing twelve months it is -2.71%. Its 52-week range spans $1.58 to $4.87. Analyst consensus is buy with an average price target of $2.98. Rallies surfaces CLOV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What are CLOV's key financials?
CLOV financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CLOV recently traded at $3.59. Market cap is $1.79B. P/E ratio is 0.00. Revenue is $2.21B.
CLOV financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CLOV recently traded at $3.59. Market cap is $1.79B. P/E ratio is 0.00. Revenue is $2.21B.
Is CLOV research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CLOV. It does not provide personalized investment advice.
